Dentalcare logo

Cardiovascular Drugs in the Top 200: Clinical Implications

COURSE NUMBER: 493

Credit Hours:

3 Hour(s)

This continuing education course introduces evidence-based information related to risk stratification of patients based on procedure-specific and patient-specific factors with special reference to the pharmacology of cardiovascular drugs, i...

View More

(Use this feature to create assignments for your students and staff.)

Overview

This continuing education course introduces evidence-based information related to risk stratification of patients based on procedure-specific and patient-specific factors with special reference to the pharmacology of cardiovascular drugs, including their mechanisms of action, indications for their use, and associated adverse drug events.


The risk of perioperative cardiac complications associated with dental treatment depends on procedure-specific and patient-specific factors. Important co-determinants of patient-specific risk factors include disease-related factors, the patient’s functional capacity, and pharmacotherapeutic variables. This course presents information essential for risk stratification of patients with cardiac dysfunction based on cardiovascular pharmacotherapy predicated on the top 200 drugs dispensed by U.S. community pharmacies.


The goal of this course is to introduce evidence-based information related to risk stratification of patients based on procedure-specific and patient-specific factors with special reference to the pharmacology of cardiovascular drugs, including their mechanisms of action, indications for their use, and associated adverse drug events.

  • Intended Audience:

    Dental Hygiene Students, Dental Hygienists, Dental Students, Dentists

  • Date Course Online:

    Jan 31, 2016

  • Last Revision Date:

    Dec 31, 2000

  • Course Expiration Date:

    Jan 30, 2019

  • Cost:

    Free

  • Method:

    Self-instructional

  • AGD Subject Code(s):

Learning Objectives

Upon completion of this course, the dental professional should be able to:


- Identify and discuss potential dental procedure-specific cardiovascular risk factors.


- Identify and discuss patient-specific risk factors.


- Discuss cardiovascular pharmacology.


- Identify cardiovascular diseases based on the patient’s drug history.


- Determine perioperative cardiac risk based of procedure- and patient-specific risk factors.

Disclaimers

Participants must always be aware of the hazards of using limited knowledge in integrating new techniques or procedures into their practice. Only sound evidence-based dentistry should be used in patient therapy. Note:  Registration is required to take test.

Author(s)

Conflict of Interest Disclosure Statement

  • Drs. Banasik, Al-saadi and Faddoul report no conflicts of interest associated with this course.
  • Dr. Terézhalmy has done consulting work for Procter & Gamble and has served on the dentalcare.com Advisory Board.

Submission Information

Recognition

AGD Pace Logo

Approved PACE Program Provider

THE PROCTER & GAMBLE COMPANY


Nationally Approved PACE Program Provider for FAGD/MAGD credit.

Approval does not imply acceptance by any regulatory authority or AGD endorsement.


8/1/2021 to 7/31/2027

Provider ID# 211886